$14.39
6.43%
Nasdaq, Sep 05, 10:00 pm CET
ISIN
US5907171046
Symbol
MESO

Mesoblast Limited Sponsored ADR Target price 2025 - Analyst rating & recommendation

Mesoblast Limited Sponsored ADR Classifications & Recommendation:

Buy
80%
Hold
20%

Mesoblast Limited Sponsored ADR Price Target

Target Price $2.03
Price $14.39
Deviation
Number of Estimates 4
4 Analysts have issued a price target Mesoblast Limited Sponsored ADR 2026 . The average Mesoblast Limited Sponsored ADR target price is $2.03. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 8 Analysts recommend Mesoblast Limited Sponsored ADR to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Mesoblast Limited Sponsored ADR stock has an average upside potential 2026 of . Most analysts recommend the Mesoblast Limited Sponsored ADR stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Jun '25 2026
Estimates
Revenue Million $ 17.20 67.69
191.53% 293.55%
EBITDA Margin -478.49% -62.19%
56.85% 87.00%
Net Margin -593.84% -351.02%
60.17% 40.89%

6 Analysts have issued a sales forecast Mesoblast Limited Sponsored ADR 2026 . The average Mesoblast Limited Sponsored ADR sales estimate is

$67.7m
Unlock
. This is
293.55% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$82.5m 379.83%
Unlock
, the lowest is
$56.8m 230.47%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $17.2m 191.53%
2026
$67.7m 293.55%
Unlock
2027
$216m 218.64%
Unlock
2028
$542m 151.14%
Unlock
2029
$510m 5.79%
Unlock
2030
$805m 57.75%
Unlock
2031
$1.3b 63.96%
Unlock
2032
$948m 28.18%
Unlock

6 Mesoblast Limited Sponsored ADR Analysts have issued a net profit forecast 2026. The average Mesoblast Limited Sponsored ADR net profit estimate is

$-238m
Unlock
. This is
132.62% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-40.3m 60.52%
Unlock
, the lowest is
$-489m 378.94%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-102m 16.12%
2026
$-238m 132.62%
Unlock
2027
$-7.1m 97.01%
Unlock
2028
$291m 4,198.17%
Unlock

Net Margin

2025 -593.84% 60.17%
2026
-351.02% 40.89%
Unlock
2027
-3.30% 99.06%
Unlock
2028
53.79% 1,730.00%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Jun '25 2026
Estimates
Earnings Per Share $ -0.08 -0.19
11.11% 137.50%
P/E negative
EV/Sales 24.19

6 Analysts have issued a Mesoblast Limited Sponsored ADR forecast for earnings per share. The average Mesoblast Limited Sponsored ADR EPS is

$-0.19
Unlock
. This is
137.50% lower
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.03 62.50%
Unlock
, the lowest is
$-0.38 375.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.08 11.11%
2026
$-0.19 137.50%
Unlock
2027
$-0.01 94.74%
Unlock
2028
$0.23 2,400.00%
Unlock

P/E ratio

Current -179.88 140.19%
2026
-77.52 56.90%
Unlock
2027
-2,590.46 3,241.67%
Unlock
2028
63.21 102.44%
Unlock

Based on analysts' sales estimates for 2026, the Mesoblast Limited Sponsored ADR stock is valued at an EV/Sales of

24.19
Unlock
and an P/S ratio of
24.68
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 95.20 34.06%
2026
24.19 74.59%
Unlock
2027
7.59 68.62%
Unlock
2028
3.02 60.18%
Unlock
2029
3.21 6.14%
Unlock
2030
2.03 36.61%
Unlock
2031
1.24 39.01%
Unlock
2032
1.73 39.23%
Unlock

P/S ratio

Current 97.12 27.96%
2026
24.68 74.59%
Unlock
2027
7.75 68.62%
Unlock
2028
3.08 60.18%
Unlock
2029
3.27 6.14%
Unlock
2030
2.08 36.61%
Unlock
2031
1.27 39.01%
Unlock
2032
1.76 39.23%
Unlock

Current Mesoblast Limited Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BELL POTTER SECURITIES
Locked
Locked
Locked Jul 17 2025
CANTOR FITZGERALD
Locked
Locked
Locked Jul 17 2025
JEFFERIES
Locked
Locked
Locked Jul 17 2025
PIPER SANDLER COMPANIES
Locked
Locked
Locked Jul 08 2025
MAXIM GROUP
Locked
Locked
Locked Jul 02 2025
PIPER SANDLER COMPANIES
Locked
Locked
Locked Apr 06 2025
JEFFERIES
Locked
Locked
Locked Mar 05 2025
Analyst Rating Date
Locked
BELL POTTER SECURITIES:
Locked
Locked
Jul 17 2025
Locked
CANTOR FITZGERALD:
Locked
Locked
Jul 17 2025
Locked
JEFFERIES:
Locked
Locked
Jul 17 2025
Locked
PIPER SANDLER COMPANIES:
Locked
Locked
Jul 08 2025
Locked
MAXIM GROUP:
Locked
Locked
Jul 02 2025
Locked
PIPER SANDLER COMPANIES:
Locked
Locked
Apr 06 2025
Locked
JEFFERIES:
Locked
Locked
Mar 05 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today